Older adults reporting food insecurity have a greater risk of developing dementia over 4 years compared with food-secure peers, results of a large US study show.
Leading UK Alzheimer's organizations have launched an ambitious plan to have a diagnostic Alzheimer's blood test widely available within the next 5 years.
The antiamyloid monoclonal antibody gantenerumab led to a lower amyloid plaque burden but no clear cognitive benefit in early Alzheimer's disease in twin pivotal trials.
Breakthrough Alzheimer’s treatments that remove toxic proteins from the brain have revived interest in vaccines to treat the memory-robbing disease, potentially offering a cheaper, easy-to-administer option for millions of people, according to interviews with 10 scientists and company executives.
Atrial fibrillation is linked to an increased risk for dementia, particularly when diagnosed before age 65 years, a large population-based study shows.
A steady decrease in deep sleep -- otherwise known as slow-wave sleep -- has been linked to an increased risk for dementia, including Alzheimer’s disease in those over age 60.